Detalhe da pesquisa
1.
Amyloid-ß levels and cognitive trajectories in non-demented pTau181-positive subjects without amyloidopathy.
Brain
; 145(11): 4032-4041, 2022 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35973034
2.
Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer's type.
Brain
; 145(7): 2507-2517, 2022 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35088840
3.
Disentangling the relationship of subjective cognitive decline and depressive symptoms in the development of cognitive decline and dementia.
Alzheimers Dement
; 19(5): 2056-2068, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36218120
4.
Don't forget about tau: the effects of ApoE4 genotype on Alzheimer's disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment-data from the Dementia Competence Network.
J Neural Transm (Vienna)
; 129(5-6): 477-486, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35061102
5.
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview.
Alzheimers Dement
; 18(10): 1868-1879, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34936194
6.
Biomarkers for the Diagnosis of Alzheimer's Disease in Clinical Practice: The Role of CSF Biomarkers during the Evolution of Diagnostic Criteria.
Int J Mol Sci
; 23(15)2022 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35955728
7.
Cerebrospinal fluid α synuclein concentrations in patients with positive AD biomarkers and extrapyramidal symptoms.
J Neural Transm (Vienna)
; 128(6): 817-825, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34036433
8.
PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment.
Acta Neuropathol
; 139(6): 1025-1044, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32166339
9.
First amyloid ß1-42 certified reference material for re-calibrating commercial immunoassays.
Alzheimers Dement
; 16(11): 1493-1503, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32755010
10.
Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest.
J Neurol Neurosurg Psychiatry
; 90(7): 740-746, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30981993
11.
Analysis of Surface Levels of IL-1 Receptors and Macrophage Scavenger Receptor I in Peripheral Immune Cells of Patients With Alzheimer Disease.
J Geriatr Psychiatry Neurol
; 32(4): 211-220, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31018751
12.
Amyloid ß oligomers (AßOs) in Alzheimer's disease.
J Neural Transm (Vienna)
; 125(2): 177-191, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29196815
13.
The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review.
Alzheimers Dement
; 14(10): 1313-1333, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29940161
14.
Cellular Receptors of Amyloid ß Oligomers (AßOs) in Alzheimer's Disease.
Int J Mol Sci
; 19(7)2018 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29954063
15.
Surface Trafficking of APP and BACE in Live Cells.
Traffic
; 16(6): 655-75, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25712587
16.
Plasma levels of sRANKL and OPG are associated with atherogenic cytokines in patients with intermediate cardiovascular risk.
Heart Vessels
; 32(11): 1304-1313, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28567553
17.
Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic.
Alzheimers Dement
; 13(1): 45-58, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27870940
18.
Excessive daytime sleepiness in a patient with coexisting myotonic dystrophy type 1, myasthenia gravis and Graves' disease.
Neurol Neurochir Pol
; 51(2): 190-193, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28209438
19.
Homocysteine metabolism is associated with cerebrospinal fluid levels of soluble amyloid precursor protein and amyloid beta.
J Neurochem
; 139(2): 324-332, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27507672
20.
SUCLG2 identified as both a determinator of CSF Aß1-42 levels and an attenuator of cognitive decline in Alzheimer's disease.
Hum Mol Genet
; 23(24): 6644-58, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25027320